Concepedia

Eznal Izwadi Bin Mohd Mahidin

EI

Statistics

Publications

2

Citations

120

H-Index

2

Active since

2023

Affiliations

National Taiwan University Hospital(Current)

Acıbadem University

National Cancer Centre Singapore

Novartis (Switzerland)

Cairo University

Eznal Izwadi Bin Mohd Mahidin is an author at National Taiwan University Hospital specializing in breast cancer hormonal therapy, hormonal cancer therapy, and oncology.

Publications per year

2023–2024

2

Publications

2

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim et al. · Journal of Clinical Oncology · 2024 · 79 citations · Full text

, , +17

Abstract GS1-10: Primary results from the randomized Phase II RIGHT Choice trial of premenopausal patients with aggressive HR+/HER2− advanced breast cancer treated with ribociclib + endocrine therapy vs physician’s choice combination chemotherapy

Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim et al. · Cancer Research · 2023 · 41 citations

, , +16

1–2 of 2